Upexi, Inc. (NASDAQ:UPXI – Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 39,300 shares, an increase of 88.9% from the February 28th total of 20,800 shares. Based on an average daily volume of 129,000 shares, the days-to-cover ratio is currently 0.3 days. Approximately 3.8% of the company’s shares are short sold.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Upexi stock. Bank of Montreal Can bought a new position in shares of Upexi, Inc. (NASDAQ:UPXI – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,008 shares of the company’s stock, valued at approximately $36,000. Bank of Montreal Can owned about 0.81% of Upexi as of its most recent SEC filing. 5.68% of the stock is currently owned by hedge funds and other institutional investors.
Upexi Price Performance
NASDAQ UPXI opened at $2.24 on Friday. Upexi has a twelve month low of $2.17 and a twelve month high of $15.91. The stock has a fifty day simple moving average of $3.20 and a 200 day simple moving average of $4.01. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.53 and a current ratio of 0.58.
Upexi Company Profile
Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.
Further Reading
- Five stocks we like better than Upexi
- The Basics of Support and Resistance
- MarketBeat Week in Review – 03/24 – 03/28
- What Are Some of the Best Large-Cap Stocks to Buy?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Buy P&G Now, Before It Sets A New All-Time High
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.